ISG20 and brain neoplasm: The fixed effect model of meta-survival analysis showed that ISG20 overexpression was associated with unfavorable prognosis of patients with brain tumor (P < 0.001, HR = 1.17, 95% CI: 1.08–1.27; Fig. 3).